Daiichi Sankyo

December 5, 2015, Simcere and Daiichi Sankyo entered into a long-term strategic partnership in China. Simcere will have an exclusive right to promote and distribute Olmetec Plus® in China.

Olmetec Plus®, an anti-hypertension oral combination of olmesartan medoxomil and hydrochlorothiazide, was developed by Daiichi Sankyo and launched in China in 2012.
© Copyright 2016 www.simcere.com All Rights Reserved.